These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 3877181)

  • 21. [125I] 3-quinuclidinyl 4-iodobenzilate: a high affinity, high specific activity radioligand for the M1 and M2-acetylcholine receptors.
    Gibson RE; Rzeszotarski WJ; Jagoda EM; Francis BE; Reba RC; Eckelman WC
    Life Sci; 1984 Jun; 34(23):2287-96. PubMed ID: 6727565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Benzodiazepine receptor and cerebral blood flow in early Alzheimer's disease--SPECT study using 123I-iomazenil and 123I-IMP].
    Kitamura S; Koshi Y; Komiyama T; Sakayori O; Komaba Y; Ohyama M; Mishina M; Tsuganesawa T; Terashi A
    Kaku Igaku; 1996 Jan; 33(1):49-56. PubMed ID: 8819714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic simulations of SPECT quantitation of the M2 muscarinic neuroreceptor subtype in disease states using radioiodinated (R,R)-4IQNB.
    Zeeberg BR; Kim HJ; Reba RC
    Life Sci; 1992; 51(9):661-70. PubMed ID: 1501511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concerning the distribution of cerebral muscarinic acetylcholine receptors in Alzheimer's disease.
    Zeeberg B
    Arch Neurol; 1991 Nov; 48(11):1117-8. PubMed ID: 1953390
    [No Abstract]   [Full Text] [Related]  

  • 25. Synthesis and biodistribution of iodine-125-labeled 1-azabicyclo[2.2.2]oct-3-yl alpha-hydroxy-alpha-(1-iodo-1-propen-3-yl)-alpha-phenylacetate. A new ligand for the potential imaging of muscarinic receptors by single photon emission computed tomography.
    McPherson DW; DeHaven-Hudkins DL; Callahan AP; Knapp FF
    J Med Chem; 1993 Apr; 36(7):848-54. PubMed ID: 8464039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of FDG PET and IQNB SPECT in normal subjects and in patients with dementia.
    Weinberger DR; Jones D; Reba RC; Mann U; Coppola R; Gibson R; Gorey J; Braun A; Chase TN
    J Neuropsychiatry Clin Neurosci; 1992; 4(3):239-48. PubMed ID: 1498576
    [TBL] [Abstract][Full Text] [Related]  

  • 27. External imaging of cerebral muscarinic acetylcholine receptors.
    Eckelman WC; Reba RC; Rzeszotarski WJ; Gibson RE; Hill T; Holman BL; Budinger T; Conklin JJ; Eng R; Grissom MP
    Science; 1984 Jan; 223(4633):291-3. PubMed ID: 6608148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regional covariance of muscarinic acetylcholine receptors in Alzheimer's disease using (R, R) [(123)I]-QNB SPECT.
    Colloby SJ; McKeith IG; Wyper DJ; O'Brien JT; Taylor JP
    J Neurol; 2015 Sep; 262(9):2144-53. PubMed ID: 26122542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Binding of radioiodinated SPECT ligands to transfected cell membranes expressing single muscarinic receptor subtypes.
    Zeeberg BR; Gitler MS; Baumgold J; de la Cruz RA; Reba RC
    Biochem Biophys Res Commun; 1991 Sep; 179(2):768-75. PubMed ID: 1898398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brain perfusion imaging in Parkinson's disease and Alzheimer's disease demonstrated by three-dimensional surface display with 123I-iodoamphetamine.
    Tachibana H; Kawabata K; Tomino Y; Sugita M; Fukuchi M
    Dementia; 1993; 4(6):334-41. PubMed ID: 8136897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-binding relationship of quinuclidinyl benzilate analogs on N4TG1 neuroblastoma muscarinic receptors.
    Chang YF
    Neurochem Res; 1988 May; 13(5):455-62. PubMed ID: 3405371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An assessment of the role of 123I-N-isopropyl-p-iodoamphetamine with single-photon emission computed tomography in the diagnosis of stroke and Alzheimer's disease.
    Killen AR; Oster G; Colditz GA
    Nucl Med Commun; 1989 Apr; 10(4):271-84. PubMed ID: 2662071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [3H]QNB displays in vivo selectivity for the m2 subtype.
    Gitler MS; De la Cruz R; Zeeberg BR; Reba RC
    Life Sci; 1994; 55(19):1493-508. PubMed ID: 7968217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Three-dimensional surface display with 123I-IMP brain perfusion imaging in patients with dementia].
    Tomino Y; Tachibana H; Sugita M
    Rinsho Shinkeigaku; 1994 Apr; 34(4):318-25. PubMed ID: 8026123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomised placebo controlled study to assess the effects of cholinergic treatment on muscarinic receptors in Alzheimer's disease.
    Kemp PM; Holmes C; Hoffmann S; Wilkinson S; Zivanovic M; Thom J; Bolt L; Fleming J; Wilkinson DG
    J Neurol Neurosurg Psychiatry; 2003 Nov; 74(11):1567-70. PubMed ID: 14617718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variability of cerebral blood flow defects in Alzheimer's disease on 123iodo-isopropyl-amphetamine and single photon emission tomography.
    Derouesne C; Rancurel G; Le Poncin Lafitte M; Rapin JR; Lassen MA
    Lancet; 1985 Jun; 1(8440):1282. PubMed ID: 2860485
    [No Abstract]   [Full Text] [Related]  

  • 37. Iodine-123 labelled Z-(R,R)-IQNP: a potential radioligand for visualization of M(1 )and M(2) muscarinic acetylcholine receptors in Alzheimer's disease.
    Bergström KA; Halldin C; Savonen A; Okubo Y; Hiltunen J; Nobuhara K; Swahn CG; Karlsson P; McPherson D; Knapp FF; Larsson S; Schnell PO; Farde L
    Eur J Nucl Med; 1999 Nov; 26(11):1482-5. PubMed ID: 10552091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo competition studies of Z-(-,-)-[125I]IQNP against 3-quinuclidinyl 2-(5-bromothienyl)-2-thienylglycolate (BrQNT) demonstrating in vivo m2 muscarinic subtype selectivity for BrQNT.
    Cohen VI; Zeeberg BR; Boulay SF; Sood VK; Rayeq MR; Danesh RA; McPherson DW; Reba RC
    J Mol Neurosci; 1998 Aug; 11(1):1-9. PubMed ID: 9826782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro and in vivo characteristics of [iodine-125] 3-(R)-quinuclidinyl (S)-4-iodobenzilate.
    Gibson RE; Schneidau TA; Cohen VI; Sood V; Ruch J; Melograna J; Eckelman WC; Reba RC
    J Nucl Med; 1989 Jun; 30(6):1079-87. PubMed ID: 2738688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SPET imaging of central muscarinic receptors with (R,R)[123I]-I-QNB: methodological considerations.
    Norbury R; Travis MJ; Erlandsson K; Waddington W; Owens J; Ell PJ; Murphy DG
    Nucl Med Biol; 2004 Jul; 31(5):583-90. PubMed ID: 15219276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.